EXC
64
3
DFS
47
8
AFL
49
3
IFF
29
2
CLX
66
-2
ECL
59
2
ILMN
51
6
MKC
63
-2
FLR
33
4
HON
55
3
NKE
43
-7
EBAY
29
2
MCD
73
2
KMX
44
2
MDLZ
83
6
EL
43
6
VZ
52
2
NAVI
44
6
OKE
67
2
STT
50
3
EXC
64
3
DFS
47
8
AFL
49
3
IFF
29
2
CLX
66
-2
ECL
59
2
ILMN
51
6
MKC
63
-2
FLR
33
4
HON
55
3
NKE
43
-7
EBAY
29
2
MCD
73
2
KMX
44
2
MDLZ
83
6
EL
43
6
VZ
52
2
NAVI
44
6
OKE
67
2
STT
50
3
Financhill
Back

Cogent Biosciences 10K Form

Sell
36

COGT
Cogent Biosciences

Last Price:
10.42
Seasonality Move:
-5.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-10 10Q COGT/Cogent Biosciences Quarterly
2020-05-11 10Q COGT/Cogent Biosciences Quarterly
2020-03-13 10K COGT/Cogent Biosciences Annual
2019-11-12 10Q COGT/Cogent Biosciences Quarterly
2019-08-09 10Q COGT/Cogent Biosciences Quarterly
2019-05-10 10Q COGT/Cogent Biosciences Quarterly

Receive COGT News And Ratings

See the #1 stock for the next 7 days that we like better than COGT

COGT Financial Statistics

Sales & Book Value

Annual Sales: $7.87M
Cash Flow: $-31.38M
Price / Cash Flow: 0
Annual Sales: $2.72
Price / Book: 3.84

Profitability

EPS (TTM): -2.45000
Net Income (TTM): $-140.24M
Gross Margin: $72.86M
Return on Equity: 0%
Return on Assets: 0%

Cogent Biosciences Earnings Forecast

Key Cogent Biosciences Financial Ratios

  • The Gross Profit Margin over the past 5 years for COGT is 871.53%.
  • The Selling, General & Administrative Expenses for COGT have been equal to 221.35% of Gross Profit Margin.
  • Per Share Earnings over the last 10 years have been positive in 3 years.

Cogent Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: COGT
CUSIP: 19240Q
Website: cogentbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

COGT Technical Analysis vs Fundamental Analysis

Sell
36
Cogent Biosciences (COGT) is a Sell

Is Cogent Biosciences a Buy or a Sell?